Section 12-280-137 - Investigations of suspicious drugs

All prescription drug outlets, manufacturers, repackagers, and wholesalers shall investigate any suspect product, as defined in the DQSA and any federal regulations implementing the DQSA, and shall use documentation and reporting procedures relating to the investigation in accordance with the DQSA and any federal regulations implementing the DQSA.Added by 2021 Ch. 314,§ 20, eff. 9/1/2021.